<p>WARMINSTER, Pa., Oct. 18, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its ex
The only expiry of note is at a strike price of 1.0900 in EUR/USD for 630m euro amount. A little further out, on Monday is – 1.9bn AUD expiry in AUD/USD at 0.6530
Leave a Comment